Last reviewed · How we verify
NCT02879981
A Safety Study of Balsamic Bactrim in Pediatric Participants With Acute Bronchitis
trial testing Guaifenesin in Bronchitis in 51 participants. Completed in 28 August 2017.
28 August 2017
Quick facts
| Lead sponsor | Hoffmann-La Roche |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 51 |
| Start date | 10 November 2016 |
| Primary completion | 28 August 2017 |
| Estimated completion | 28 August 2017 |
| Sites | 3 locations across Peru |
Drugs / interventions tested
- Guaifenesin (guaifenesin) — full drug profile →
- Sulfamethoxazole (SULFAMETHOXAZOLE) — full drug profile →
- Trimethoprim (TRIMETHOPRIM) — full drug profile →
Conditions studied
- Bronchitis — all drugs for Bronchitis →
Sponsor
Hoffmann-La Roche — full company profile →
Who can join
Adults 4 to 14, any sex, with Bronchitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This pilot, multicentric and observational study will assess the safety of sulfamethoxazole + trimethoprim + guaifenesin (Balsamic Bactrim) in pediatric participants with acute bronchitis. Administration of treatment will be according to treating physician's recommendation under local labeling.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A pilot study of safety of sulfamethoxazole, trimethoprim and guaifenesin in pediatric and adult patients with acute bronchitis.
Falcon M, Iberico C, Guerra F, Reyes I, et al · · 2019 · PMID 30832720 · DOI 10.1186/s13104-019-4150-2
Verify or expand the search:
- PubMed search for NCT02879981
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Guaifenesin
Trials testing the same drug.
- NCT07398924 — Vaginal Estradiol and Oral Guaifenesin in Clomiphene Ovulation Induction · NA · completed
- NCT02902640 — A Non-Interventional Safety Study of Balsamic Bactrim · completed
Other recruiting trials for Bronchitis
Currently open trials in the same condition.
- NCT06528418 — Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath · recruiting
Other Hoffmann-La Roche trials
Trials by the same sponsor.
- NCT07503340 — A Study to Evaluate Pharmacokinetics, Safety, Tolerability, Immunogenicity and Pharmacodynamic Effects of Subcutaneous O · Phase 2 · not yet recruiting
- NCT07298421 — A Study to Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance Therapy in · Phase 3 · recruiting
- NCT07059273 — A COPD Data Registry for Participants With Frequent Exacerbations · not yet recruiting
- NCT07416526 — A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A · Phase 3 · recruiting
- NCT05199688 — A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric · Phase 3 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02879981 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hoffmann-La Roche
- Last refreshed: 13 December 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02879981.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing